Video: Early cancer diagnosis seems crucial in children with immune defect

Video: Early cancer diagnosis seems crucial in children with immune defect

(Vienna, 03.12.2020) CD27/CD70 deficiencies can lead to cancer in small children: “If diagnosed at an early stage, the majority of these patients are responsive to the hematopoietic stem cell treatment”, says Co-first author Sevgi Köstel Bal, MD, Phd, St. Anna Children's Cancer Research Institute (CCRI)’s, in a video statement on…

Cancer in children with rare inborn immune defect: High cure rate if treated early

Cancer in children with rare inborn immune defect: High cure rate if treated early

(Vienna, 03.12.2020) New research data highlight a marked predisposition to lymphoma, a type of cancer, in children harboring specific gene mutations. A significant fraction of these rare mutations also cause inborn immune defects associated with recurrent infections. Collaborating closely with leading centers across the world, researchers investigated patients bearing recently…

Selected for funding:  Training a new generation of childhood cancer scientists

Selected for funding: Training a new generation of childhood cancer scientists

(Vienna, 24.11.2020) St. Anna Children’s Cancer Research Institute is part of a European Marie Sklodowska-Curie Actions Innovative Training Network ITN. Being awarded with this grant, Prof. Heinrich Kovar, PhD, is looking forward to train an international PhD student within the VAGABOND program. The successful candidate will investigate druggable molecular pathways…

Dream Job Childhood Cancer Scientist: "Always a step ahead of the tumor"

Dream Job Childhood Cancer Scientist: "Always a step ahead of the tumor"

(Vienna, 14.09.2020) Sabine Taschner-Mandl, PhD, aims to achieve a long-term benefit for children with cancer via research. She heads the Tumor Biology group at St. Anna Children's Cancer Research Institute and, on the occasion of Childhood Cancer Awareness Month September, explains how she is pursuing her goal and what it…

Childhood Cancer Neuroblastoma: Not only DNA, it´s also the age that matters

Childhood Cancer Neuroblastoma: Not only DNA, it´s also the age that matters

(Vienna, 09.09.2020) Scientists at St. Anna Children's Cancer Research Institute provide an important new insight in neuroblastoma, the most common solid tumor in infants and young children: the influence of genome alterations on the course of disease in certain neuroblastomas depends also on age. The results, published in the renowned…

Cure Childhood Cancer? Challenge accepted, says Prof. Heinrich Kovar

Cure Childhood Cancer? Challenge accepted, says Prof. Heinrich Kovar

(Vienna, 07.09.2020) Prof. Heinrich Kovar PhD, heads the Molecular Biology of Solid Tumors group at St. Anna Children's Cancer Research Institute. He was one of the Institute’s founders and its scientific director for 17 years. The molecular biologist provided essential knowledge for a better understanding of Ewing sarcoma, an aggressive…